HOLLYWOOD, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- nFusz,

New Post Public Reply Private Reply Replies (0) Message Board
adirondackhi
597
HOLLYWOOD, Calif., Jan. 11, 2019 (GLOBE NEWSWIRE) -- nFusz, Inc. (OTCQB: FUSZ), a leader in business-focused interactive video, and the pioneer of Augmented Sales Intelligence software, announced it has entered into a partnership with Instapage, the global leader in post-click optimization, to incorporate interactive video capabilities from the nFusz platform into Instapage landing pages. nFusz, Inc. will become the first next-generation video partner to be made available to Instapage's 15,000 enterprise clients including Verizon, eBay, TrueCar among others, across 100 countries who collectively have created over 1 million Instapage landing pages.

"The ability for marketing professionals and agencies to create custom, engaging post-click experiences at scale has yielded average conversion rates above 22%," stated Yon Xiao, Director of Product at Instapage. "We've previously been limited in regard to the video analytics we've been able to offer our clients. However, customers will have complete transparency in calculating their video marketing ROI with the full suite of video analytics offered by nFusz," continued Mr. Xiao.

"In today's video centric world, video has rapidly become an essential element of any marketing strategy," stated Rory J. Cutaia, CEO of nFusz. "Armed with the knowledge that consumers retain 95% more of the messaging communicated through video in comparison to standard text, marketers have pushed video into the forefront of the marketing landscape for 2019. For marketers using the Instapage platform, the ability to enjoy the same custom, engaging experience to their video content is a complete home run. Conversion rates above 22% are certainly impressive, though we will look to add value by bolstering the conversion rates of Instapage users across the board through the use of our interactive video technology," continued Mr. Cutaia.

About nFusz, Inc.

nFusz, Inc. (OTCQB: FUSZ) is a recognized leader in business-focused interactive video and the pioneer of Augmented Sales Intelligence software. The company's flagship product, notifiCRM, is the first interactive video-based customer relationship management (CRM) platform that allows anyone to create, distribute, post, track, and measure interactive videos that increase engagement and conversion rates by up to 600 percent. Video viewers can respond to one or more calls to action by clicking within a video while it's playing -- and no download is required. nFusz products are cloud-based, Software-as-a-Service (SaaS), available by subscription for individual and enterprise users, and accessible on all mobile and desktop devices. The company's newest products, also based on its interactive video technology platform, include notifiMED, for the healthcare industry, notifiEDU, for the education industry, and notifiNGO, for non-profit organizations. For more information on nFusz, Inc., visit: https://nfusz.com/

About Instapage

Instapage is the leader in post-click optimization and maximizes conversions for advertisers and marketers by enabling them to create, personalize, and optimize post-click experiences at scale. With more than a million customer landing pages at an average conversion rate above 22%, Instapage is helping more than 15,000 clients across 100 countries capture more value from their campaigns. For more information on Instapage, visit: https://instapage.com/

TON Strategy Co. (TONX) Stock Research Links

TONX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

transcosmos Secures Special Jury Award for Outstanding Strategy

Updated Category News Views 157

Transcosmos Achieves Recognition at Contact Center Awards Recognized for clear, goal-oriented strategy working together with clients. TOKYO /PRNewswire/ -- transcosmos is thrilled to share that the company has been awarded the Special Jury Award in the Strategy category at the Contact Center Awards 2025. This prestigious event is sponsored by the Editorial Office of...

Continue Reading
HCW Biologics Partners with WY Biotech for Innovative Licensing Deal

Updated Category News Views 121

HCW Biologics Collaborates with WY Biotech on a Licensing Agreement HCW Biologics has taken an exciting step forward by entering into a license agreement with WY Biotech for a transformative preclinical immunotherapeutic product candidate. This partnership positions both companies to harness innovative technologies in the biopharmaceutical landscape. Financial Aspects of...

Continue Reading
Bucked Up® Unveils Hunt: Orange Cream—Limited Edition

Updated Category News Views 14

The Buzz Behind Bucked Up®'s Limited-Edition Flavor You know, there's caffeine, and then there's Bucked Up®'s caffeine kick—it’s a whole different animal. But now they’ve spiced things up a notch with their new Hunt: Orange Cream flavor. It’s plastered on every product from their line, from Bucked Up® to the wacky-named Woke AF®. Feels like they’re saying,...

Continue Reading
Transform Your Investment: The Growth of SPS Commerce Over Time

Updated Category News Views 53

The Impressive Growth of SPS Commerce SPS Commerce (NASDAQ: SPSC) has carved out a strong position in the market, consistently providing remarkable returns. Over the last 15 years, this company has outpaced average market growth by a staggering 13.26% each year, resulting in an average annual return of 25.11%. As of now, SPS Commerce enjoys a robust market capitalization...

Continue Reading
Exploring QIAGEN's Commitment to Newborn Genomic Sequencing

Updated Category News Views 106

Innovating Genomic Sequencing for Newborns QIAGEN (NYSE: QGEN) is making significant strides in the field of genomic medicine by partnering with Genomics England on a remarkable initiative aimed at sequencing the genomes of newborns. This pioneering effort seeks to screen for over 200 genetic conditions, facilitating early diagnosis and intervention for rare health...

Continue Reading